Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Hepatocellular 15Biliary Tract Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Liver Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Advanced Endometrial Cancer 2Thyroid Neoplasms 1Solid Tumors 1Recurrence 1Neoplasm Metastasis 1Hepatitis B 1Esophageal Squamous Cell Carcinoma 1Diabetes Mellitus, Insulin-Dependent, 12 1Cirrhosis, Familial, with Pulmonary Hypertension 1Breast Neoplasms 1Bone Neoplasms 1BTC 1Advanced Triple Negative Breast Cancer 1Advanced Non-squamous Non-small-cell Lung Cancer 1Advanced Hepatocellular Carcinoma (HCC) 1Adenocarcinoma 1

Interventions

lenvatinib 1alectinib 1Proton Therapy 1Indocyanine Green 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Bone Neoplasms × lenvatinib × Clear all
NCT07619950 2026-06-02

EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma

Yonsei University

Phase 2 Not yet recruiting
94 enrolled
Sarcoma

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡